|
|
Other links at Articles > Pediatrics |
| 4. |
Amifostine Lowers Risk of Cisplatin-Related Hearing Loss in Children
|
|
|
A cytoprotective adjuvant used in cancer chemotherapy, amifostine, reduces the likelihood of ototoxicity in children undergoing cisplatin therapy for medulloblastoma, according to a study by U.S. and Australian researchers reported in the August 1 issue of the Journal of Clinical Oncology. Reuters Health Information
|
|
|